Cargando…
False positive results using calcitonin as a screening method for medullary thyroid carcinoma
The role of serum calcitonin as part of the evaluation of thyroid nodules has been widely discussed in literature. However there still is no consensus of measurement of calcitonin in the initial evaluation of a patient with thyroid nodule. Problems concerning cost-benefit, lab methods, false positiv...
Autores principales: | Batista, Rafael Loch, Toscanini, Andrea Cecilia, Brandão, Lenine Garcia, Cunha-Neto, Malebranche Berardo C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712390/ https://www.ncbi.nlm.nih.gov/pubmed/23869316 http://dx.doi.org/10.4103/2230-8210.111677 |
Ejemplares similares
-
Serum calcitonin negative Medullary thyroid carcinoma
por: Sand, Michael, et al.
Publicado: (2006) -
Calcitonin receptor expression in medullary thyroid carcinoma
por: Cappagli, Virginia, et al.
Publicado: (2017) -
Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma
por: Yue, Wenliang, et al.
Publicado: (2022) -
Update on Calcitonin Screening for Medullary Thyroid Carcinoma and the Results of a Retrospective Analysis of 12,984 Patients with Thyroid Nodules
por: Broecker-Preuss, Martina, et al.
Publicado: (2023) -
Falsely Positive Parathyroid Scan in a Patient With Medullary Thyroid Cancer
por: Khthir, Rodhan Abass
Publicado: (2021)